Skip to main content
logo
Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
5.62
-0.33 (-5.55%)
Jul 31, 2026, 4:00 PM EDT - Market closed

Basel Medical Group Financials Overview

Millions SGD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
14.5511.3210.059.710.66
Revenue Growth
28.55%12.63%3.60%-8.98%-
Gross Profit
1.882.374.164.124.45
Operating Income
-4.6-12.62.121.962.15
Net Income
-10.05-10.642.071.782.39
Earnings Per Share
-6.81-6.841.561.321.44
EPS Growth
--18.18%-8.33%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
1.343.041.951.221.56
Total Debt
8.985.084.297.2110.15
Net Cash (Debt)
-7.64-2.03-2.34-6-8.59
Net Cash Growth
-----
Net Cash Per Share
-0.41-1.30-1.73-4.43-6.34

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-1.89-4.042.512.62.79
Capital Expenditures
-0.66-0.56-0.01-0.01-0.09
Free Cash Flow
-2.56-4.62.52.592.7
Free Cash Flow Growth
---3.56%-4.07%-

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
12.92%20.93%41.43%42.44%41.74%
Operating Margin
-31.59%-111.33%21.09%20.18%20.20%
Pretax Margin
-71.47%-97.65%23.92%21.97%22.39%
Profit Margin
-69.81%-93.96%20.62%18.38%22.39%
FCF Margin
-17.58%-40.64%24.89%26.74%25.37%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
0.773.75---